Lifestyle modification and endothelial function in obese subjects

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 2, 2005, Pages 231-241

  Hamdy, Osama ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular risk; Cytokine; Diet; Endothelial function; Exercise; Insulin sensitivity; Lifestyle; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CHOLESTEROL; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; METFORMIN; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DIET RESTRICTION; DYSLIPIDEMIA; ENDOTHELIUM; ENDOTHELIUM LESION; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HIGH RISK PATIENT; HUMAN; HYPERCOAGULABILITY; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; METABOLIC REGULATION; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; REVIEW; THROMBOSIS; WEIGHT REDUCTION;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; CYTOKINES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; HUMANS; INSULIN; OBESITY; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 15844410509     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.3.2.231     Document Type: Review

References (124)

1. Modan M, Halkin H, Almong S et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J. Clin. Invest. 75, 809-817 (1985).
2. Reaven GM. Banting lecture 1988: role of insulin resistance in human diabetes. Diabetes 37, 1595-1607 (1988).
3. Balkau B, Charles MA, Drivsholm T et al., the European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 28(5), 364-376 (2002).
4. Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults. J. Am. Med. Assoc. 287(3), 356-359 (2002).
5. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165(2), 285-292 (2002).
6. Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. New Engl. J. Med. 346(6), 393-403 (2002).
7. Hamdy O, Ledbury S, Mullooly C et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26(7), 2119-2125 (2003).
8. Monzillo LU, Hamdy O, Horton ES et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res. 11(9), 1048-1054 (2003).
9. Jarrett R, McCartney P, Keen H, The Bedford survey: 10 year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycemic controls and risk indices for coronary heart disease in borderline diabetes. Diabetologia 22, 79-82 (1982).
10. Balkau B, Eschwege E, Papoz L et al. Risk factors for early death in noninsulin dependent diabetes and men with known glucose intolerance status. Brit. Med. J. 307, 295-299 (1993).
11. Fuchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376 (1980).
12. Van Voorde J, Leusen I. Role of the endothelium in the vasodilator response of rat thoracic aorta to histamine. Eur. J. Phamacol. 87, 113-120 (1983).
13. Oyama Y, Kawasaki H, Ratton Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta of diabetic rats. Eur. J. Phamacol. 131, 75-78 (1986).
14. McVeigh GE, Brennan G, Johnston GD. Impaired endothelium-dependent and independent vasodilatation in patients with Type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 35, 771-776 (1992).
15. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilatation in participants with noninsulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 27, 567-574 (1996).
16. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97(11), 2601-2610 (1996).
17. Caballero AE, Arora S, Saouaf R et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for Type 2 diabetes. Diabetes 48(9), 1856-1862 (1999).
18. Tooke JE, Hannemann MM. Adverse endothelial function and the insulin resistance sydrome. J. Intern. Med. 247(74), 425-431 (2000).
19. Chowienczyk PJ, Barnes DJ, Brett SE, Cockcroft JR, Viberti GC, Ritter JM. Correction of impaired NO-mediated vasodilation by L-arginine in noninsulin dependent diabetes. Endothelium 3, 955 (1995) (Abstract).
20. Wascher TC, Graier WF, Dittrich P et al. Effects of low-dose L-arginine on insulin-mediated vasodilation and insulin sensitivity. Eur. J. Clin Invest. 27, 690-695 (1997).
21. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C impoves endothelium dependent vasodilation in patients with noninsulin-dependent diabetes mellitus. J. Clin. Invest. 97, 22-28 (1996).
22. Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali J-R, Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in noninsulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97, 736-743 (1998).
23. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87, 432-438 (1991).
24. Gearing AJH, Hemingway J, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann. NY Acad. Sci. 667, 324-331 (1992).
25. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br. J. Haematol. 92, 747-750 (1996).
26. Kado S, Nagata N. Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with Type 2 diabetes mellitus. Diabetes Res. Clin. Prac. 46(2), 143-148 (1999).
27. Campbell JH, Campbell GR. Cell biology of atherosclerosis. J. Hypertension 12, S129-S132 (1994).
28. Gray RP, Yudkin JS, Patterson DL. Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients. Brit. Heart J. 69(3), 228-232 (1993).
29. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocrine Rev. 22(1), 36-52 (2001).
30. Bergman RN, Mittelman SD. Central role of the adipocyte in insulin resistance. J. Basic Clin. Physiol. Pharmacol. 9(2-4), 205-221 (1998).
31. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol. Chem. 270(45), 26746-26749 (1995).
32. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance-the emerging role of the adipocyte as an endocrine organ. N. Engl. J. Med. 345(18), 1345-1346 (2001).
33. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant anti-atherogenic effect in elderly women. Circulation 107(12), 1626-1631 (2003).
34. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46(5), 860-867 (1997).
35. Maeda N, Shimomura I, Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Med. 8(7), 731-737 (2002).
36. Okamoto Y, Kihara S, Ouchi N et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106(22), 2767-2770 (2002).
37. Minamikawa J, Yamauchi M, Inoue D, Koshiyama H. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83(3), 1041-1042 (1998).
38. Bilsborough W, O'Driscoll G, Stanton K et al. Effect of lowering tumor necrosis factor-α on vascular endothelial function in Type II diabetes. Clin. Sci. 103(2), 163-169 (2002).
39. Matsuda M, Shimomura I, Sata M et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis. J. Biol. Chem. 277(40), 37487-37491 (2002).
40. Dzielinska Z, Januszewicz A, Wiecek A et al. Decreased plasma concentration of a novel anti-inflammatory protein - adiponectin - in hypertensive men with coronary artery disease. Thromb. Res. 110(5-6), 365-369 (2003).
41. Dua A, Hennes MI, Hoffmann RG et al. Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 45(11), 1635-1637 (1996).
42. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19(4), 972-978 (1999).
43. Vgontzas AN, Papanicolaou DA, Bixter EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82(5), 1313-1316 (1997).
44. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95(5), 2409-2415 (1995).
45. Jovinge S, Hamsten A, Tornvall P et al. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronay heart disease. Metabolism 47(1), 113-118 (1998).
46. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J. Clin. Invest.100(11), 2777-2782 (1997).
47. Patel JN, Jager A, Schalkwijk C et al. Effects of tumour necrosis factor-α in the human forearm: blood flow and endothelin-1 release. Clin. Sci. (Lond.) 103(4), 409-415 (2002).
48. Zeng M, Zhang H, Lowell C, He P. Tumor necrosis factor-α-induced leukocyte adhesion and microvessel permeability. Am J. Physiol. Heart Circ. Physiol. 283(6), H2420-H2430 (2002).
49. Ashton AW, Ware GM, Kaul DK, Ware JA. Inhibition of tumor necrosis factor-α mediated NFκB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G-protein-linked receptor (TP) ligands. J. Biol. Chem. 278(14), 11858-11866 (2003).
50. Park SH, Park JH, Kang JS, Kang YH. Involvement of transcription factors in plasma HDL protection against TNF-α-induced vascular cell adhesion molecule-1 expression. Int. J. Biochem. Cell. Biol. 35(2), 168-182 (2003).
51. Uzui H, Harpf A, Liu M et al. Increased expression of membrane Type 3-matrix metalloproteinase in human atherosclerosis plaque: role of activated macrophages and inflammatory cytokines. Circulation 106(24), 3024-3030 (2002).
52. Yuan M, Konstantopoulos N, Lee J et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293(5535), 1673-1677 (2001).
53. Nonogaki K, Fuller GM, Fuentes NL et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136(5), 2143-2149 (1995).
54. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19(4), 972-978 (1999).
55. Romano M, Sironi M, Toniatti C et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte. Immunity 6(3), 315-325 (1997).
56. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101(15), 1767-1772 (2000).
57. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc. Immunol. Rev. 8, 6-48 (2002).
58. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. FASEB J. 17, 884-886 (2003).
59. Baldeweg SE, Pink AM, Yudkin JS, Coppack SW. The relationship between obesity, vascular reactivity and endothelial dysfunction in subjects with noninsulin dependent diabetes mellitus. Int. J. Obes. 24, S134-S135 (2000).
60. Ross R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340(2), 115-126 (1999).
61. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med. 7(8), 941-946 (2001).
62. Katsuki A, Sumida Y, Murashima S et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83(3), 859-862 (1998).
63. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-α. J. Biol. Chem. 266(32), 21839-21845 (1991).
64. Hotamisligil GS, Peraldi P, Budavari A et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271(5249), 665-668 (1996).
65. Strassman G, Fong M, Windsor S, Neta R. The Role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 5(4), 285-290 (1993).
66. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin-6, and risk of developing Type 2 diabetes mellitus. J. Am. Med. Assoc. 286(3), 327-334 (2001).
67. Ventre J, Doebber T, Wu M et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 46(9), 1526-1531 (1997).
68. Hofman C, Lorenz K, Braithwaite SS et al. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134(1), 264-270 (1994).
69. Peraldi P, Xu M, Spiegelman BM. Thiazolidinediones block tumor necrosis factor-α-induced inhibition of insulin signaling. J. Clin. Invest. 100(7), 1863-1869 (1997).
70. Satoh N, Ogawa Y, Usui T et al. Antiatherogenic effect of pioglitazone in Type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect, Diabetes Care 26(9), 2493-2499 (2003).
71. Hambrecht R, Fiehn E, Weigl C et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98, 2709-2715 (1998).
72. Callaerts-Vegh Z, Wenk M, Goebbels U et al. Influence of intensive physical training on urinary nitrate elimination and plasma endothelin-1 levels in patients with congestive heart failure. J. Cardiopulm. Rehab. 18, 450-457 (1998).
73. Griffin K, Laughlin MH, Parker J. Exercise training improves endothelium-mediated vasorelaxation after chronic coronary occlusion. J. Appl. Physiol. 87(5), 1948-1956 (1999)
74. Kingwell BA. Nitric oxide as a metabolic regulator during exercise: effects of training in health and disease. Clin. Exp. Pharm. Physiol. 27, 239-250 (2000).
75. Hambrecht R, Wolf A, Gielen S et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N. Engl. J. Med. 342(7), 454-460 (2000).
76. Clarkson P, Montgomery HE, Mullen MJ et al. Exercise training enhances endothelial function in young men. J. Am. Coll. Cardiol. 33, 1379-1385 (1999).
77. Kingwell BA, Sherrard B, Jennings GL, Dart AM. 4 weeks of cycle training increases basal production of nitric oxide from the forearm. Am. J. Physiol. 272, H1070-H1077 (1997).
78. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over 1 year. Circulation 105(7), 804-809 (2002).
79. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351(9096), 88-92 (1998).
80. Sciacqua A, Candigliota M, Ceravolo R et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 26(6), 1673-1678 (2003).
81. Nicoletti G, Giugliano G, Pontillo A et al. Effect of a multidisciplinary program of weight reduction on endothelial functions in obese women. J. Endocrinol. Invest. 26(3), RC5-RC8 (2003).
82. McNally PG, Lawrence IG, Watt PA, Hillier C, Burden AC, Thurston H. The effect of insulin on the vascular reactivity of isolated resistance arteries taken from healthy volunteers. Diabetologia 38(4), 467-473 (1995).
83. Sakamoto S, Minami K, Niwa Y et al. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous NIDDM. Diabetes 47(1), 82-86 (1998).
84. Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA, Van Bortel LM. The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J. Hypertens. 17(12 Pt 2), 1831-1835 (1999).
85. Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch JR. Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J. Am. Coll. Cardiol. 38(5), 1313-1319 (2001).
86. Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome. Arterioscler. Thromb. Vasc. Biol.20(2), 551-555 (2000).
87. Maiorana A, O'Driscoll G, Cheetham C et al. The effect of combined aerobic and resistance exercise training on vascular function in Type 2 diabetes. J. Am. Coll. Cardiol. 38(3), 860-866 (2001).
88. Fuchsjager-Maryl G, Pleiner J, Wiesinger FG et al. Exercise training improves vascular endothelial function in patients with Type 1 diabetes. Diabetes Care 25(10), 1795-1801 (2002).
89. Karason K, Wikstrand J, Sjostrom L, Wendelhag I. Weight loss and progression of early atherosclerosis in the carotid artery: a 4-year controlled study of obese subjects. Int. J. Obes. Relat. Metab. Disord. 23(9), 948-956 (199).
90. Sasaki S, Higashi Y, Nakagawa K et al. A low-calorie diet improves endothelium-dependent vasodilatation in obese patients with essential hypertension. Am. J. Hypertens. 15(4 Pt 1), 302-309 (2002).
91. Raitaki M, Ilvonen T, Ahotupa M et al. Weight reduction with very-low-caloric diet endothelial function in overweight adults: role of plasma glucose. Arterioscler. Thromb. Vasc. Biol. 24(1), 124-128 (2004).
92. Carluccio MA, Siculella L, Ancora MA et al. Olive oil and red wine anti-oxidant polyphenols inhibit endothelial activation: anti-atherogenic properties of Mediterranean diet phytochemicals. Arterioscler. Thromb. Vasc. Biol. 23(4), 622-629 (2003).
93. Yildirir A, Tokgozoglu SL, Oduncu T et al. Soy protein diet significantly improves endothelial function and lipid parameters. Clin. Cardiol. 24(11), 711-716 (2001).
94. Miyashita Y, Koide N, Ohtsuka M et al. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in Type 2 diabetic patients with obesity. Diabetes Res. Clin. Prac. 65(3), 235-241 (2004).
95. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L, XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of Type 2 diabetes in obese patients. Diabetes Care 27(1), 155-161 (2004).
96. Tuomilehto J, Lindstrom J, Eriksson JG et al. Finnish Diabetes Prevention Study Group. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344(18), 1343-1350 (2001).
97. Fuchsjager-Maryl G, Pleiner J, Wiesinger GF et al. Exercise training improves vascular endothelial function in patients with Type 1 diabetes. Diabetes Care 25(10), 1795-1801 (2002).
98. Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med. 2(7), 800-803 (1996).
99. Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in Type 2 diabetes. Atherosclerosis 166(2), 387-394 (2003).
100. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43(1), 104-109 (1994).
101. Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A. Weight change and blood coagulability and fibrinolysis in healthy obese women. Int. J. Obes. Relat. Metab. Disord. 25(2), 212-218 (2001).
102. Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103(8), 1057-1063 (2001).
103. Hamdy O, Moussa A, Ledbury S et al. Effects of weight loss and increased physical activity on insulin and glucose dynamics in obese subjects with insulin resistance syndrome. Diabetes 51(Suppl. 2), A60 (2002).
104. Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85(9), 3338-3342 (2000).
105. Milan G, Granzotto M, Scarda A et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes. Res. 10(11), 1095-1103 (2002).
106. Ryan AS, Nicklas BJ, Berman DM, Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int. J Obes. Relat. Metab. Disord. 27(9), 1066-1071 (2003).
107. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metabol. 88(4), 1594-1602 (2003).
108. Yang WS, Lee WJ, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metabol. 86(8), 3815-3819 (2001).
109. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, Campbell LV. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 27(2), 629-630 (2004).
110. Kraemer RR, Aboudehen KS, Carruth AK et al. Adiponectin responses to continuous and progressively intense intermittent excercise. Med. Sci. Sports. Exerc. 35(8), 1320-1325 (2003).
111. Hulver MW, Zheng D, Tanner CJ et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am. J. Physiol. Endocrinol. Metabol. 283(4), E861-E865 (2002).
112. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier JF. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in Type 2 diabetic men. Eur. J. Endocrinol. 149(5), 421-424 (2003).
113. Sherman WM, Friedman JE, Gao JP, Reed MJ, Elton CW, Dohm GL. Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rate. Med. Sci. Sports Exerc. 25(3), 341-348 (1993).
114. Ren JM, Semenkovich CF, Gulve EA, Gao J, Holloszy JO. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, an insulin-stimulated glycogen storage in muscle. J. Biol. Chem. 269(20), 14396-14401 (1994).
115. Ivy JL, Kuo CH. Regulation of GLUT4 protein and glycogen synthase during muscle glycogen synthesis after exercise. Acta Physiol. Scand. 162(3), 295-304 (1998).
116. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW, Chisholm DJ. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care 26(6), 1706-1713 (2003).
117. Thomas EL, Brynes AE, McCarthy J et al. Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids 35(7), 769-776 (2000).
118. Kim YW, Kim JY, Lee SK. Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue on monosodium glutamate (MSG)-obese rats. J. Korean Med. Sci. 14(5), 539-545 (1999).
119. Barzilai N, She L, Liu BQ et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48(1), 94-98 (1999).
120. Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P. A Pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int. J. Obes. Relat. Metab. Disord. 26(2), 193-199 (2002).
121. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann. Intern. Med. 136(7), 493-503 (2002).
122. Kumagai S, Kai Y, Hanada H, Uezono K, Sasaki H. Relationships of the systolic blood pressure response during exercise with insulin resistance, obesity, and endurance fitness in men with Type 2 diabetes mellitus. Metabolism 51(10), 1247-1252 (2002).
123. Miyatake N, Takahashi K, Wada J et al. Daily exercise lowers blood pressure and reduces visceral adipose tissue areas in overweight Japanese men. Diabetes Res. Clin. Prac. 62(3), 149-157 (2003).
124. Takahashi H, Nishimura M, Yoshimura M. Roles of cytokines on blood pressure regulation. Nippon Rinsho 50(Suppl.), 134-139 (1992).